info@seagull-health.com
SeagullHealth
语言:
search

Mektovi(Binimetinib) Side Effects

Common side effects of Binimetinib include liver toxicity, gastrointestinal issues, and skin reactions.

Side Effects of Binimetinib Tablets

Binimetinib Tablets can cause a range of side effects, including hepatic toxicity, which may manifest as elevated liver enzymes or liver failure in severe cases. Common gastrointestinal side effects include nausea, vomiting, and diarrhea, which can impact the patient's quality of life. Skin reactions such as rash, pruritus, or acneiform eruptions have also been observed. Other adverse events may include fatigue, headache, and fever. Severe reactions should be monitored and may require dose adjustment or temporary discontinuation of treatment. Patients should be informed about the potential side effects and managed accordingly.

Binimetinib(Mektovi)
Binimetinib(Mektovi)
Adults with advanced or metastatic melanoma with BRAF V600E or V600K mutation.
WeChat Scan
Free Inquiry
Related articles
Side Effects of Binimetinib (Mektovi)
Binimetinib (Mektovi) is a selective mitogen-activated protein kinase (MEK) inhibitor. It primarily blocks the RAS/RAF/MEK/ERK signaling pathway by inhibiting the activity of MEK1 and MEK2, thereby su...
Are the adverse effects of Binimetinib(Mektovi) serious?
The severity of adverse reactions to Binimetinib(Mektovi) varies from individual to individual, but in general, most adverse reactions are manageable and not too severe, but some may be serious and re...
Side effects of Binimetinib
Binimetinib is a reversible inhibitor of mitogen-activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 activity, and has shown good efficacy in the treatment of BRAF mutation-positive unre...
What are the adverse reactions of Binimetinib(Mektovi)?
Binimetinib is a targeted therapy for metastatic or unresectable melanoma with BRAF V600E or V600K mutations, and has achieved remarkable efficacy in clinical applications. Like other drugs, Binimetin...
共 4 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved